Transfusion  ||| S:0 E:12 ||| NNP
and  ||| S:12 E:16 ||| CC
risk  ||| S:16 E:21 ||| NN
of  ||| S:21 E:24 ||| IN
acute  ||| S:24 E:30 ||| JJ
kidney  ||| S:30 E:37 ||| NN
injury  ||| S:37 E:44 ||| NN
in  ||| S:44 E:47 ||| IN
cardiac  ||| S:47 E:55 ||| JJ
surgery  ||| S:55 E:63 ||| NN
Acute  ||| S:63 E:69 ||| NNP
kidney  ||| S:69 E:76 ||| NN
injury  ||| S:76 E:83 ||| NN
( ||| S:83 E:84 ||| -LRB-
AKI ||| S:84 E:87 ||| NNP
)  ||| S:87 E:89 ||| -RRB-
is  ||| S:89 E:92 ||| VBZ
a  ||| S:92 E:94 ||| DT
serious  ||| S:94 E:102 ||| JJ
and  ||| S:102 E:106 ||| CC
common  ||| S:106 E:113 ||| JJ
complication  ||| S:113 E:126 ||| NN
of  ||| S:126 E:129 ||| IN
major  ||| S:129 E:135 ||| JJ
surgery ||| S:135 E:142 ||| NN
.  ||| S:142 E:144 ||| .
This  ||| S:144 E:149 ||| DT
narrative  ||| S:149 E:159 ||| JJ
review  ||| S:159 E:166 ||| NN
focuses  ||| S:166 E:174 ||| VBZ
on  ||| S:174 E:177 ||| IN
the  ||| S:177 E:181 ||| DT
relationship  ||| S:181 E:194 ||| NN
between  ||| S:194 E:202 ||| IN
perioperative  ||| S:202 E:216 ||| JJ
red  ||| S:216 E:220 ||| JJ
blood  ||| S:220 E:226 ||| NN
cell  ||| S:226 E:231 ||| NN
transfusion  ||| S:231 E:243 ||| NN
and  ||| S:243 E:247 ||| CC
AKI  ||| S:247 E:251 ||| NNP
after  ||| S:251 E:257 ||| IN
cardiac  ||| S:257 E:265 ||| JJ
surgery  ||| S:265 E:273 ||| NN
with  ||| S:273 E:278 ||| IN
cardiopulmonary  ||| S:278 E:294 ||| JJ
bypass  ||| S:294 E:301 ||| NNS
( ||| S:301 E:302 ||| -LRB-
CPB ||| S:302 E:305 ||| NNP
) ||| S:305 E:306 ||| -RRB-
.  ||| S:306 E:308 ||| .
Numerous  ||| S:308 E:317 ||| JJ
observational  ||| S:317 E:331 ||| JJ
studies  ||| S:331 E:339 ||| NNS
have  ||| S:339 E:344 ||| VBP
shown  ||| S:344 E:350 ||| VBN
that  ||| S:350 E:355 ||| IN
these  ||| S:355 E:361 ||| DT
two  ||| S:361 E:365 ||| CD
factors  ||| S:365 E:373 ||| NNS
are  ||| S:373 E:377 ||| VBP
independently  ||| S:377 E:391 ||| RB
associated  ||| S:391 E:402 ||| VBN
with  ||| S:402 E:407 ||| IN
each  ||| S:407 E:412 ||| DT
other ||| S:412 E:417 ||| JJ
.  ||| S:417 E:419 ||| .
Several  ||| S:419 E:427 ||| JJ
lines  ||| S:427 E:433 ||| NNS
of  ||| S:433 E:436 ||| IN
evidence  ||| S:436 E:445 ||| NN
suggest  ||| S:445 E:453 ||| VBP
that  ||| S:453 E:458 ||| IN
the  ||| S:458 E:462 ||| DT
nature  ||| S:462 E:469 ||| NN
of  ||| S:469 E:472 ||| IN
this  ||| S:472 E:477 ||| DT
association  ||| S:477 E:489 ||| NN
is  ||| S:489 E:492 ||| VBZ
one  ||| S:492 E:496 ||| CD
of  ||| S:496 E:499 ||| IN
cause  ||| S:499 E:505 ||| NN
and  ||| S:505 E:509 ||| CC
effect ||| S:509 E:515 ||| NN
.  ||| S:515 E:517 ||| .
The  ||| S:517 E:521 ||| DT
pathophysiological  ||| S:521 E:540 ||| JJ
mechanism  ||| S:540 E:550 ||| NN
by  ||| S:550 E:553 ||| IN
which  ||| S:553 E:559 ||| WDT
transfusions  ||| S:559 E:572 ||| NNS
might  ||| S:572 E:578 ||| MD
harm  ||| S:578 E:583 ||| VB
the  ||| S:583 E:587 ||| DT
kidney  ||| S:587 E:594 ||| NN
has  ||| S:594 E:598 ||| VBZ
not  ||| S:598 E:602 ||| RB
been  ||| S:602 E:607 ||| VBN
fully  ||| S:607 E:613 ||| RB
elucidated ||| S:613 E:623 ||| JJ
,  ||| S:623 E:625 ||| ,
but  ||| S:625 E:629 ||| CC
it  ||| S:629 E:632 ||| PRP
is  ||| S:632 E:635 ||| VBZ
known  ||| S:635 E:641 ||| VBN
that  ||| S:641 E:646 ||| IN
erythrocytes  ||| S:646 E:659 ||| FW
undergo  ||| S:659 E:667 ||| FW
irreversible  ||| S:667 E:680 ||| FW
morphological  ||| S:680 E:694 ||| FW
and  ||| S:694 E:698 ||| CC
biochemical  ||| S:698 E:710 ||| JJ
changes  ||| S:710 E:718 ||| NNS
during  ||| S:718 E:725 ||| IN
storage ||| S:725 E:732 ||| NN
.  ||| S:732 E:734 ||| .
As  ||| S:734 E:737 ||| IN
a  ||| S:737 E:739 ||| DT
result ||| S:739 E:745 ||| NN
,  ||| S:745 E:747 ||| ,
after  ||| S:747 E:753 ||| IN
transfusion ||| S:753 E:764 ||| NN
,  ||| S:764 E:766 ||| ,
they  ||| S:766 E:771 ||| PRP
can  ||| S:771 E:775 ||| MD
promote  ||| S:775 E:783 ||| VB
a  ||| S:783 E:785 ||| DT
pro-inflammatory  ||| S:785 E:802 ||| JJ
state ||| S:802 E:807 ||| NN
,  ||| S:807 E:809 ||| ,
impair  ||| S:809 E:816 ||| JJ
tissue  ||| S:816 E:823 ||| NN
oxygen  ||| S:823 E:830 ||| NN
delivery ||| S:830 E:838 ||| NN
,  ||| S:838 E:840 ||| ,
and  ||| S:840 E:844 ||| CC
exacerbate  ||| S:844 E:855 ||| JJ
tissue  ||| S:855 E:862 ||| NN
oxidative  ||| S:862 E:872 ||| NN
stress ||| S:872 E:878 ||| NN
.  ||| S:878 E:880 ||| .
This  ||| S:880 E:885 ||| DT
in  ||| S:885 E:888 ||| IN
turn  ||| S:888 E:893 ||| NN
can  ||| S:893 E:897 ||| MD
cause  ||| S:897 E:903 ||| VB
AKI  ||| S:903 E:907 ||| NNP
in  ||| S:907 E:910 ||| IN
susceptible  ||| S:910 E:922 ||| JJ
patients  ||| S:922 E:931 ||| NNS
undergoing  ||| S:931 E:942 ||| VBG
cardiac  ||| S:942 E:950 ||| JJ
surgery  ||| S:950 E:958 ||| NN
with  ||| S:958 E:963 ||| IN
CPB ||| S:963 E:966 ||| NNP
,  ||| S:966 E:968 ||| ,
such  ||| S:968 E:973 ||| JJ
as  ||| S:973 E:976 ||| IN
those  ||| S:976 E:982 ||| DT
with  ||| S:982 E:987 ||| IN
pre-existing  ||| S:987 E:1000 ||| JJ
kidney  ||| S:1000 E:1007 ||| NN
dysfunction  ||| S:1007 E:1019 ||| NNS
or  ||| S:1019 E:1022 ||| CC
anaemia ||| S:1022 E:1029 ||| NN
.  ||| S:1029 E:1031 ||| .
Interventions  ||| S:1031 E:1045 ||| NNS
aimed  ||| S:1045 E:1051 ||| VBN
at  ||| S:1051 E:1054 ||| IN
avoiding  ||| S:1054 E:1063 ||| VBG
perioperative  ||| S:1063 E:1077 ||| JJ
blood  ||| S:1077 E:1083 ||| NN
transfusion  ||| S:1083 E:1095 ||| NN
might ||| S:1095 E:1100 ||| MD
,  ||| S:1100 E:1102 ||| ,
therefore ||| S:1102 E:1111 ||| RB
,  ||| S:1111 E:1113 ||| ,
reduce  ||| S:1113 E:1120 ||| VB
the  ||| S:1120 E:1124 ||| DT
risk  ||| S:1124 E:1129 ||| NN
of  ||| S:1129 E:1132 ||| IN
AKI  ||| S:1132 E:1136 ||| NNP
after  ||| S:1136 E:1142 ||| IN
cardiac  ||| S:1142 E:1150 ||| JJ
and  ||| S:1150 E:1154 ||| CC
other  ||| S:1154 E:1160 ||| JJ
types  ||| S:1160 E:1166 ||| NNS
of  ||| S:1166 E:1169 ||| IN
surgery ||| S:1169 E:1176 ||| NN
.  ||| S:1176 E:1178 ||| .
